The latest report by IMARC Group, titled “ADME Toxicology Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2032,” offers a comprehensive analysis of the ADME toxicology testing market overview. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global ADME toxicology testing market size reached US$ 9.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 26.1 Billion by 2032, exhibiting a growth rate (CAGR) of 11.9% during 2024-2032.
Request a Sample Report: https://www.imarcgroup.com/adme-toxicology-testing-market/requestsample
ADME Toxicology Testing Market Trends:
The global market is primarily driven by the increasing emphasis on drug safety and efficacy in pharmaceutical development. In line with this, the widespread adoption of advanced ADME (Absorption, Distribution, Metabolism, and Excretion) toxicology testing methods is also providing an impetus to the market. Moreover, the significant rise in the number of clinical trials and new drug approvals is acting as a considerable growth-inducing factor for the market. In addition to this, the escalating focus on personalized medicine and the development of targeted therapies is leading to higher investments in ADME toxicology testing.
Besides this, the growing demand for high-throughput screening and in-vitro testing methods due to their cost-effectiveness and accuracy is creating lucrative opportunities in the market. Also, the rising influence of regulatory authorities in mandating stringent safety assessments is positively impacting the market. The market is further driven by the implementation of various guidelines aimed at reducing the incidence of adverse drug reactions.
ADME Toxicology Testing Market Scope and Growth Analysis:
The scope of the global market is expanding as pharmaceutical and biotechnology companies increasingly invest in ADME toxicology testing to enhance drug development processes. In this context, the proliferation of innovative in-silico and in-vitro models is enhancing the market's potential. Moreover, the increasing collaboration between academia and industry players is facilitating the development of cutting-edge testing methodologies, as per the market analysis. The rising trend of outsourcing ADME toxicology testing to specialized contract research organizations (CROs) is also broadening the market's scope.
In addition to this, the integration of ADME testing with drug discovery platforms is enabling more efficient and accurate drug candidate selection. Besides this, the focus on reducing drug development timelines and costs is driving the adoption of advanced testing technologies. The market is also benefiting from the growing emphasis on regulatory compliance and the harmonization of testing standards globally. Furthermore, the emergence of novel drug delivery systems and complex biologics is adding new dimensions to ADME toxicology testing requirements.
View Full Report with TOC & List of Figure: https://www.imarcgroup.com/adme-toxicology-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Agilent Technologies Inc.
- Beckman Coulter Inc. (Danaher Corporation)
- Bioivt LLC
- Bio-Rad Laboratories Inc.
- Charles River Laboratories International Inc.
- Cyprotex Plc (Evotec AG)
- Molecular Discovery Ltd.
- Perkinelmer Inc.
- Promega Corporation
- Thermo Fisher Scientific, Inc.
ADME Toxicology Testing Market Segmentation:
Our report has categorized the market based on technology, product type, method, and application.
Breakup by Technology:
- Cell Culture
- High Throughput Screening
- Molecular Imaging
- OMICS Technology
- Others
Breakup by Product Type:
- Instruments
- Software Solutions
- Assay Systems
- Reagents
- Others
Breakup by Method:
- In-Vivo
- In-Vitro
- In-Silica
- Others
Breakup by Application:
- Systemic Toxicity
- Renal Toxicity
- Hepatotoxicity
- Neurotoxicity
- Others
Breakup by Region:
- North America (USA, Canada)
- Europe (Germany, France, UK, Italy, Spain, Russia, others)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, others)
- Middle East/Africa
- Latin America (Brazil, Mexico, others)
Key Highlights of the Report:
- Market Performance (2018-2023)
- Market Outlook (2024-2032)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About US:
IMARC Group is a leading market research firm that provides management strategy and market research worldwide. We work with clients in every sector and geography to identify their most valuable opportunities, address their most important challenges and transform their businesses.
The IMARC Group's information offerings include key market trends, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high technology sectors. Market forecasts and industry analysis in biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and innovative processing methods are among the company's top areas of expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
![ELD Compliance Software Market Share Forecast Report [2032]](https://s3.us-west-2.amazonaws.com/timessquarereporter.com/upload/media/posts/2024-09/11/eld-compliance-software-market-share-forecast-report-2032_1726054354-s.jpg)
Comments
0 comment